Stediphar SRL
1.9 FTEStediphar reported total assets of €1.09m at the end of the 2025 financial year (annual accounts filed with the NBB on 27 Aug 2026), with 1.9 full-time equivalent.
The score of Stediphar shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Equity +51 % Total assets +1 % Headcount (avg FTE) +27 %
Accounts of the company itself (not consolidated).
The full file covers 10 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Stediphar's annual accounts
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Net result | 207,443 € | ||||
| Equity | 325,335 € | ||||
| Cash | 53,865 € | ||||
| EBITDA | 240,470 € | ||||
| Total assets | €1.09m |
Filed annual accounts
- Year ended 31 Dec 2025filed on 27 Aug 2026
- Year ended 31 Dec 2024filed on 28 Aug 2025
- Year ended 31 Dec 2023filed on 29 Aug 2024
- Year ended 31 Dec 2022filed on 16 Aug 2023
- Year ended 31 Dec 2021filed on 08 Aug 2022
Stediphar's financial analysis
- Solvency30.0%sector median: 44.2%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Stediphar
Stediphar's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0477.059.361
- VAT number
- BE0477059361
- Peppol
- Registered · 0208:0477059361 · as of 10 Nov 2026
- Legal form
- SRL
- Incorporated
- 11 Mar 2002
- Registered office
- 8400 Ostend
- Size
- Micro · 1.9 FTE
- Latest accounts
- 2025 · filed on 27 Aug 2026
- Activity
- Retail sale of pharmaceutical products (NACE 47730)
Stediphar (SRL) has been based in Ostend since 2002, active in: retail sale of pharmaceutical products. For 2025, it reports a net profit of 207,443 € and equity of 325,335 €; its revenue is not published. With 1.9 full-time equivalents, it is a micro-enterprise by headcount. Its solvency stands at 30.0%, below the median of its sector (44.2%).
Guide: Reading Belgian SME accounts: the five figures that count →
Companies similar to Stediphar
Companies in the same business, of comparable size and area, outside its group.
- Pharmacie Bauduin Retail sale of pharmaceutical products Brussels · balance sheet €1.09m
- Ap. Pharmamax Retail sale of pharmaceutical products Boom · balance sheet €1.09m
- Apotheek Sarah Haentjens Retail sale of pharmaceutical products Ronse · balance sheet €1.09m
- P. Corstiens Farma Retail sale of pharmaceutical products Westerlo · balance sheet €1.09m
- Assentfarma Retail sale of pharmaceutical products Bekkevoort · balance sheet €1.08m
- Fardil Retail sale of pharmaceutical products Dilbeek · balance sheet €1.10m
- Holsbeek Brasschaat Retail sale of pharmaceutical products Brasschaat · balance sheet €1.10m
- De Maeyer Retail sale of pharmaceutical products Dilbeek · balance sheet €1.07m
Frequently asked questions about Stediphar
What is the revenue of Stediphar?
Stediphar files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of Stediphar?
In Belgium, the VAT number is the company number prefixed with BE: BE0477059361 for Stediphar, if the company is VAT-registered. Its company number (CBE) is 0477.059.361.
Where is the registered office of Stediphar?
According to the CBE register, the registered office of Stediphar is in 8400 Ostend.
What is the equity of Stediphar?
At the close of the 2025 financial year, the equity of Stediphar amounts to 325,335 €, a solvency of 30.0% of total assets.
How many people work at Stediphar?
1.9 full-time equivalents on average according to the 2025 social balance sheet.
Who manages Stediphar?
The register lists 4 active mandates at Stediphar. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Stediphar
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →